The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a rare form of obesity caused ...
In a lab study, a combo of anti-aging drugs appeared to cause a profound loss of the protective coating myelin, which is a ...
Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired ...
Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity, a rare condition in which damage to or a malfunction of the hypothalamus leads to excessive weight gain ...
Not clear that Ricky Hatton intended to take his own life, rules coroner - Tests showed the former Dancing On Ice contestant ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
Relapsing after quitting cocaine is not simply a matter of willpower — it reflects physical changes in the brain, according to new research. Scientists have found that repeated cocaine use reshapes ...
The Trump administration is temporarily lifting sanctions on Iranian oil stranded at sea under a one-month license.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results